CardioPulmonary Resuscitation With Argon (CPAr) Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT05482945

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05482945
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05482945. Randomized; single masking; primary purpose treatment. Start 2022-05-30 (actual); primary completion 2026-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CardioPulmonary Resuscitation With Argon (CPAr) Trial
Acronym
CPAr
Condition
Cardiac Arrest, Out-Of-Hospital
Condition
Cardiac Arrest With Successful Resuscitation
Intervention (Drug)
Noble gas Argon
Lead sponsor
Mario Negri Institute for Pharmacological Research (class: other)

Record details

Record id
cardio:ct-nct05482945
Content hash
6449b12bc3666bf9ef195cdd6d6531aaed510eb799bef4da99393a7264571747